GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Total Current Liabilities

Asia Green Biotechnology (XCNQ:ASIA) Total Current Liabilities : C$0.53 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Asia Green Biotechnology's total current liabilities for the quarter that ended in Dec. 2023 was C$0.53

Asia Green Biotechnology Total Current Liabilities Historical Data

The historical data trend for Asia Green Biotechnology's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology Total Current Liabilities Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Liabilities
Get a 7-Day Free Trial 0.09 0.03 0.04 0.25 0.53

Asia Green Biotechnology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.28 0.28 0.30 0.53

Asia Green Biotechnology Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Asia Green Biotechnology's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.29+0.237
+Other Current Liabilities+Current Deferred Liabilities
=1.1102230246252E-16+0
=0.53

Asia Green Biotechnology's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.29+0.237
+Other Current Liabilities+Current Deferred Liabilities
=1.1102230246252E-16+0
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Asia Green Biotechnology Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Asia Green Biotechnology (XCNQ:ASIA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Total Current Liabilities
Comparable Companies
TSXV:VIV XCNQ:CHM XCNQ:JOLT XCNQ:GHG XCNQ:MJRX XCNQ:XCX XCNQ:TEQ XCNQ:MOJO XCNQ:SE XCNQ:PILL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Website
https://www.asiagreenbiotechnology.com
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.
Executives
Johannes Kingma Senior Officer

Asia Green Biotechnology (XCNQ:ASIA) Headlines